| COMPANY |
GoodRx Holdings, Inc. |
| COURT |
United States District Court for the Central District of California |
| CASE NUMBER |
2:24-cv-03282-DDP-AJR |
| JUDGE |
The Hon. Dean D. Pregerson |
| CLASS PERIOD |
September 23, 2020 through November 8, 2022 |
| SECURITY TYPE |
Common Stock |
Case Background:
A class action lawsuit has been filed on behalf of those who purchased or acquired GoodRx Holdings, Inc. (“GoodRx”) (NASDAQ: GDRX) common stock between September 23, 2020 and November 8, 2022, both dates inclusive (the “Class Period”).
The Complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose that: (1) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx’s total prescription transactions revenue (the Company’s primary revenue stream); and (2) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx’s revenues for purchases at Kroger’s pharmacies; and (3) as a result, Defendants’ representations about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.
Current Status of Case:
On July 23, 2024, the Court entered an Order Appointing Lead Plaintiff and Approving Lead Counsel. The action is ongoing.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.